AdTab Dogs 11-22 Kg 3 Tablets (450 Mg)

Treatment of flea and tick infestations in dogs.

This veterinary medicinal product provides immediate and persistent flea killing (Ctenocephalides felis and C. canis) and tick killing (Rhipicephalus sanguineus, Ixodes ricinus, I. hexagonus and Dermacentor reticulatus) for 1 month.

Fleas and ticks must attach to the host and start feeding to be exposed to the active substance.

Contraindications

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Special warnings

Special precautions for safe use in the target species

Parasites must start feeding on the host to be exposed to lotilaner; therefore the risk of transmission of parasite-borne diseases cannot be completely excluded. The possibility that other animals in the same household may be a source of flea reinfection should be taken into account and these should be treated if necessary with an appropriate product. Fleas, at any stage of their development, can infest the dog's litter box and normal resting areas such as carpets and soft furnishings. In the event of a massive flea infestation, and at the start of control measures, these areas should be treated with a suitable environmental product and then cleaned regularly.

All efficacy and safety data were acquired from dogs and puppies aged 8 weeks or older and weighing 1.3 kg or more. In the absence of available data, a veterinarian should be consulted before treatment in puppies less than 8 weeks of age or with a body weight less than 1.3 kg.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Wash hands after handling the product.

In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Pregnancy and breastfeeding

Laboratory studies in rats have not shown any teratogenic effects. The safety of the veterinary medicinal product during pregnancy or lactation has not been established.

Consult a veterinarian before use during pregnancy and lactation.

Fertility

Laboratory studies in rats have not shown any adverse effects on the reproductive capacity of males and females. The safety of the medicinal product in breeding dogs has not been established.

Consult a veterinarian before treatment in breeding dogs.

Interaction with other veterinary medicinal products and other forms of interaction

None known. During clinical field studies, no interactions were observed between lotilaner and commonly used veterinary medicinal products.

Overdose

No adverse reactions were observed after oral administration to puppies aged 8 to 9 weeks with a body weight of 1.3-3.6 kg, treated with overdoses of up to 5 times the maximum recommended dose (43 mg, 129 mg and 215 mg lotilaner/kg body weight) on eight occasions at monthly intervals.

Dosage for each species, route(s) and method of administration

For oral use.

The veterinary medicinal product should be administered according to the following table to ensure a lotilaner dose of 20 to 43 mg/kg body weight.

For dogs weighing more than 45 kg, use an appropriate combination of the available strengths to achieve the recommended dose of 20-43 mg/kg.

Under-dosing may result in ineffective use and may promote the development of resistance. To ensure correct dosing, determine body weight as accurately as possible.

Recommendations for correct administration

Lotilaner Elanco is a palatable flavoured chewable tablet. Administer the chewable tablet with food or after meals.

For optimal control of flea and tick infestation, the product should be administered at monthly intervals throughout the flea and/or tick season, based on local epidemiological situations.

Special precautions for storage

Keep out of the sight and reach of children.

This veterinary medicinal product does not require any special storage conditions.

Do not use this veterinary medicinal product after the expiry date which is stated on the carton and blister after Exp. The expiry date refers to the last day of that month.

Special precautions for disposal

Medicines should not be disposed of via wastewater or household waste.

Use take-back systems for the disposal of unused veterinary medicinal products or waste materials derived from the use of such medicinal products in accordance with local requirements and any national collection systems relevant to the veterinary medicinal product concerned.

Ask your veterinary surgeon or pharmacist how to dispose of medicines you no longer require.